1. Home
  2. KRYS vs AVT Comparison

KRYS vs AVT Comparison

Compare KRYS & AVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • AVT
  • Stock Information
  • Founded
  • KRYS 2015
  • AVT 1921
  • Country
  • KRYS United States
  • AVT United States
  • Employees
  • KRYS N/A
  • AVT N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • AVT Electronic Components
  • Sector
  • KRYS Health Care
  • AVT Technology
  • Exchange
  • KRYS Nasdaq
  • AVT Nasdaq
  • Market Cap
  • KRYS 4.3B
  • AVT 4.3B
  • IPO Year
  • KRYS 2017
  • AVT N/A
  • Fundamental
  • Price
  • KRYS $144.86
  • AVT $53.94
  • Analyst Decision
  • KRYS Strong Buy
  • AVT Sell
  • Analyst Count
  • KRYS 10
  • AVT 3
  • Target Price
  • KRYS $204.90
  • AVT $49.00
  • AVG Volume (30 Days)
  • KRYS 268.2K
  • AVT 1.0M
  • Earning Date
  • KRYS 11-03-2025
  • AVT 10-29-2025
  • Dividend Yield
  • KRYS N/A
  • AVT 2.44%
  • EPS Growth
  • KRYS 36.22
  • AVT N/A
  • EPS
  • KRYS 4.91
  • AVT 2.75
  • Revenue
  • KRYS $359,205,000.00
  • AVT $22,200,754,000.00
  • Revenue This Year
  • KRYS $34.33
  • AVT $5.51
  • Revenue Next Year
  • KRYS $47.84
  • AVT $6.01
  • P/E Ratio
  • KRYS $29.46
  • AVT $19.67
  • Revenue Growth
  • KRYS 116.08
  • AVT N/A
  • 52 Week Low
  • KRYS $122.80
  • AVT $39.22
  • 52 Week High
  • KRYS $207.84
  • AVT $59.24
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 48.61
  • AVT 51.62
  • Support Level
  • KRYS $136.73
  • AVT $52.51
  • Resistance Level
  • KRYS $152.96
  • AVT $54.47
  • Average True Range (ATR)
  • KRYS 4.68
  • AVT 0.96
  • MACD
  • KRYS -0.69
  • AVT 0.00
  • Stochastic Oscillator
  • KRYS 50.09
  • AVT 55.06

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About AVT Avnet Inc.

Avnet Inc is a global distributor of electronic components, connecting suppliers of semiconductors and other components to a base of 2.1 million small- and mid-sized customers in 140 countries. Avnet is the third largest semiconductor distributor in the world, and the largest for European chip distribution. Avnet services all levels of electronics design and development, servicing engineers with design tools, test kits, and services alongside its high-volume distribution for final designs.

Share on Social Networks: